Abstract

AimsTumour necrosis factor-α (TNF-α) plays a key role in the regulation of cardiac contractility. Although cardiomyocytes are known to express the TNF-α receptors (TNFRs), the mechanism of TNF-α signal transmission is incompletely understood. The aim of this study was to investigate whether the tumour suppressor Ras-association domain family protein 1 isoform A (RASSF1A) modulates TNF-α signalling in cardiomyocytes.Methods and resultsWe used RASSF1A knockout (RASSF1A−/−) mice and wild-type (WT) littermates in this study. Acute stimulation with a low dose of TNF-α (10 µg/kg iv) increased cardiac contractility and intracellular calcium transients' amplitude in WT mice. In contrast, RASSF1A−/− mice showed a blunted contractile response. Mechanistically, RASSF1A was essential in the formation of the TNFR complex (TNFRC), where it functions as an adaptor molecule to facilitate the recruitment of TNFR type 1-associated death domain protein and TNFR-associated factor 2 to form the TNF-α receptor complex. In the absence of RASSF1A, signal transmission from the TNF-α receptor complex to the downstream effectors, such as cytoplasmic phospholipase A2 and protein kinase A, was attenuated leading to the reduction in the activation of calcium handling molecules, such as L-type Ca2+ channel and ryanodine receptors.ConclusionOur data indicate an essential role of RASSF1A in regulating TNF-α signalling in cardiomyocytes, with RASSF1A being key in the formation of the TNFRC and in signal transmission to the downstream targets.

Highlights

  • Tumour necrosis factor-a (TNF-a) is a pro-inflammatory cytokine that plays an important role in the heart, in particular, in the regulation of contractility and left ventricular (LV) remodelling

  • Ras-association domain family protein 1 isoform A (RASSF1A) was essential in the formation of the TNF-a receptors (TNFRs) complex (TNFRC), where it functions as an adaptor molecule to facilitate the recruitment of TNFR type 1-associated death domain protein and TNFR-associated factor 2 to form the TNF-a receptor complex

  • Our data indicate an essential role of RASSF1A in regulating TNF-a signalling in cardiomyocytes, with RASSF1A being key in the formation of the TNFRC and in signal transmission to the downstream targets

Read more

Summary

Introduction

Tumour necrosis factor-a (TNF-a) is a pro-inflammatory cytokine that plays an important role in the heart, in particular, in the regulation of contractility and left ventricular (LV) remodelling. Mice with cardiomyocytespecific overexpression of TNF-a developed dilated cardiomyopathy, altered cardiac contractility, and abnormal intracellular calcium dynamics.[1,2,3,4] TNF-a effects in the heart seem to be dose- and time-dependent. Treatment of adult cardiomyocytes with TNF-a for 12 h protects against hypoxic injury.[5] low dose of TNF-a treatment induces hypertrophic growth in isolated myocytes,[6] whereas acute treatment with a low dose of TNF-a produces a positive inotropic effect in conscious dogs.[7] TNF-a appears to produce biphasic effects on cardiac contractility: at low concentrations, TNF-a increases the amplitude of [Ca2+]i transients and contraction, whereas at high concentrations TNF-a impairs electrically stimulated [Ca2+]i transients and contraction.[8,9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call